A5091604315- Lung Cancer Diagnosis and Treatment
- Global Cancer Incidence and Screening
- Lung Cancer Treatments and Mutations
- Palliative Care and End-of-Life Issues
- Pulmonary Hypertension Research and Treatments
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Head and Neck Cancer Studies
- Patient-Provider Communication in Healthcare
- Respiratory Support and Mechanisms
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Family and Patient Care in Intensive Care Units
- Smoking Behavior and Cessation
- Sepsis Diagnosis and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Heart Failure Treatment and Management
- Health Systems, Economic Evaluations, Quality of Life
- Tracheal and airway disorders
- Systemic Sclerosis and Related Diseases
- Radiation Dose and Imaging
- Venous Thromboembolism Diagnosis and Management
- Emergency and Acute Care Studies
- Ultrasound in Clinical Applications
- Patient Satisfaction in Healthcare
- Healthcare cost, quality, practices
- Healthcare Policy and Management
VA Boston Healthcare System
2020-2025
Boston University
2016-2025
Veterans Health Administration
2020-2025
Pulmonary Associates
2010-2025
United States Department of Veterans Affairs
2018-2025
Edith Nourse Rogers Memorial Veterans Hospital
2014-2024
VA New England Healthcare System
2021-2024
Boston Medical Center
2012-2023
United States Department of the Navy
2023
United States Navy
2023
Background: Computed tomographic pulmonary angiography (CTPA) may improve detection of lifethreatening embolism (PE), but this sensitive test have a downside: overdiagnosis and overtreatment (finding clinically unimportant emboli exposing patients to harms from unnecessary treatment).Methods: To assess the impact CTPA on national PE incidence, mortality, treatment complications, we conducted time trend analysis using Nationwide Inpatient Sample Multiple Cause-of-Death databases.We compared...
Background: Because pulmonary nodules are found in up to 25% of patients undergoing computed tomography the chest, question whether perform biopsy is becoming increasingly common. Data on complications after transthoracic needle lung limited case series from selected institutions. Objective: To determine population-based estimates risks for a nodule. Design: Cross-sectional analysis. Setting: The 2006 State Ambulatory Surgery Databases and Inpatient California, Florida, Michigan, New York...
New-onset atrial fibrillation (AF) has been reported in 6% to 20% of patients with severe sepsis. Chronic AF is a known risk factor for stroke and death, but the clinical significance new-onset setting sepsis uncertain.To determine in-hospital mortality risks associated sepsis.Retrospective population-based cohort California State Inpatient Database administrative claims data from nonfederal acute care hospitals January 1 through December 31, 2007.Data were available 3,144,787 hospitalized...
Although there is now substantial evidence that pulmonary artery (PA) catheterization does not reduce mortality in critically ill patients, it unknown whether national utilization has decreased response.To determine trends PA use the United States.A time trend analysis on estimates of from 1993-2004 using data all US states contributing to Nationwide Inpatient Sample. Hospital admissions for those participants aged 18 years or older were assessed, with primary focused a medical diagnosis...
This article is the first of a series on overdiagnosis looking at risks and harms to patients expanding definitions disease increasing use new diagnostic technologies.
Background-Computed tomography pulmonary angiography (CTPA) may improve detection of life-threatening embolism.But this sensitive test have a downside: overdiagnosis and overtreatment (finding clinically unimportant emboli exposing patients to harms from unnecessary treatment).Methods-To assess the impact CTPA on national embolism incidence, mortality, treatment complications, we conducted time trend analysis using Nationwide Inpatient Sample Multiple Cause-of-Death databases.We compared...
Section:ChooseTop of pageAbstract <<ContentsOverviewIntroductionMethodsResultsPlanningImplementationMaintenanceConclusionsReferencesCITING ARTICLES
Background: There are well-documented disparities in lung cancer outcomes across populations. Lung screening (LCS) has the potential to reduce mortality, but for this benefit be realized by all high-risk groups, there must careful attention ensuring equitable access lifesaving preventive health measure.Objectives: To outline current knowledge on eligibility criteria for, to, and implementation of LCS, develop an official American Thoracic Society statement propose strategies optimize...
Rationale: National trends in tracheostomy for mechanical ventilation (MV) patients are not well characterized.Objectives: To investigate use, timing, and outcomes the United States.Methods: We calculated estimates of use from Inpatient Sample 1993 to 2012. used hierarchical models determine factors associated with among MV patients.Measurements Main Results: identified 1,352,432 adults who received 2012 (9.1% patients). Tracheostomy was more common surgical patients, men, racial/ethnic...
Section:ChooseTop of pageAbstract <<Materials and MethodsResultsDiscussionReferencesCITING ARTICLES
Section:ChooseTop of pageAbstract <<Executive SummaryContentsOverviewIntroductionMethodsBackgroundResultsDiscussion: Clinical Appl...ConclusionsAppendix 1: DefinitionsAppendix 2: Additional Re...ReferencesCITING ARTICLES
<h3>Importance</h3> Pulmonary nodules are common, and more will be found with implementation of lung cancer screening. How potentially malignant pulmonary evaluated may affect patient outcomes, health care costs, effectiveness screening programs. Guidelines for evaluating exist, but little is known about how in the usual setting. <h3>Objective</h3> To characterize nodule evaluation concordance guidelines. <h3>Design, Setting, Participants</h3> A retrospective cohort study was conducted...
The risks from potential exposure to coronavirus disease 2019 (COVID-19), and resource reallocation that has occurred combat the pandemic, have altered balance of benefits harms informed current (pre-COVID-19) guideline recommendations for lung cancer screening nodule evaluation. Consensus statements were developed guide clinicians managing programs patients with nodules during COVID-19 pandemic.
Section:ChooseTop of pageAbstract <<ContentsOverviewIntroductionMethodsResultsDiscussionReferencesCITING ARTICLES